Intracellular Delivery of Anti-Kirsten Rat Sarcoma Antibodies Mediated by Polymeric Micelles Exerts Strong <i>In Vitro</i> and <i>In Vivo</i> Anti-Tumorigenic Activity in Kirsten Rat Sarcoma-Mutated Cancers
Diana Rafael(University of Lisbon), Ibane Abasolo(Unknown), Joaquin Seras‐Franzoso(Vall d'Hebron Institut de Recerca), Sara Montero‐Herradón(Universitat Autònoma de Barcelona), Zamira V. Díaz‐Riascos(Vall d'Hebron Institut de Recerca), Monserrat Llaguno‐Munive(Instituto Nacional de Cancerología), Simó Schwartz(CIBBIM-Nanomedicine), Júlia German-Cortés(Universitat Autònoma de Barcelona), Begoña Fernández(Universitat Autònoma de Barcelona), Esteban F. Durán‐Lara(University of Talca), Fernanda Andrade(Universidade do Porto), Pilar Carcavilla(Universitat Autònoma de Barcelona), Alfredo Pereira(University of Chile)
Cited by 13
Related Papers
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases
|Advanced Drug Delivery Reviews|2013|237
Bacterial Inclusion Bodies: Discovering Their Better Half
|Trends in Biochemical Sciences|2017|181
Bacterial inclusion bodies: making gold from waste
|Trends in biotechnology|2011|173
Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes
|Microbial Cell Factories|2015|147
Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells
|Nanomedicine Nanotechnology Biology and Medicine|2015|85